Moreover, memory CD8+ T cells can vary in both magnitude and quality [7]–[9] and generating a central memory population with a high level expression of CD62L (TCM) yields longer lasting tumor regression compared to CD62L low effector memory cells (TEM) [10]–[12]. This evidence concerns the gene CD8A and neoplasm.